COO Stock Recent News
COO LATEST HEADLINES
Medicus Pharma (NASDAQ:MDCX) said on Monday it has appointed Andrew Smith as chief operating officer, bringing on board a seasoned asset management executive as the company accelerates its clinical development programs in the US, Europe, and the Middle East. Smith, who most recently served as CEO of SR Asset Management until its sale in 2024, brings over 30 years of experience in financial and operational leadership.
Lockheed Martin COO Frank St. John said Monday that a timeline of three to four years for building President Donald Trump's Golden Dome defense plan is "very realistic."
When it comes to short-term trading signals, few indicators are as closely tracked as the Relative Strength Index (RSI). A stock's RSI measures the speed and magnitude of its recent price movements.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Explore The Cooper Companies' (COO) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.
Cooper Companies COO delivered a solid fiscal second quarter performance in 2025, surpassing analyst expectations with $1 billion in revenue (up 6.3% YoY) and adjusted earnings per share (EPS) of 96 cents (up 14% YoY). Despite persistent macroeconomic headwinds and a slightly softened outlook for industry growth, management reaffirmed confidence in its core product momentum and operational leverage.
Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either Dentsply International (XRAY) or The Cooper Companies (COO). But which of these two stocks offers value investors a better bang for their buck right now?
Cooper Companies raised its annual profit forecast on Thursday, after beating quarterly results estimates, banking on strong demand for its contact lenses.
SAN RAMON, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal second quarter ended April 30, 2025.
David Leavy is departing his position as chief operating officer of CNN Worldwide and will return to parent Warner Bros. Discovery. Mark Thompson, chairman and CEO of CNN, wrote that Leavy “has decided to return to a role at Warner Bros. Discovery in the weeks ahead.